Albert Einstein College of Medicine Researchers Develop Promising New Cancer Therapy

/PRNewswire/ -- Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumor cells. Their...

Related Keywords

China ,United States ,Peng Xing ,Winfried Edelmann ,Louis Goldstein Swan ,Zhao Wang ,Yixian Li ,Deyou Zheng ,Xingxing Zang ,Xiaoshen Dong ,Qizhe Sun ,Devin Corrigan ,Yingzhen Su ,Xiaoxin Ren ,Yao Wei ,Xiaoyu Zhang ,Phillipm Galbo Jr ,Instagram ,Linkedin ,Twitter ,Albert Einstein College Of Medicine ,National Institutes Of Health ,Cancer Research ,University Hospital ,Youtube ,Facebook ,College Of Medicine ,Clinical Investigation ,Albert Einstein College ,Louis Goldstein Swan Chair ,Cancer Therapeutics Program ,Montefiore Einstein Cancer ,Natural Killer ,Mou Peng ,Medicinealbert Einstein College ,National Institutes ,Einstein College ,